← Browse by Condition
Medical Condition

platinum resistant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06682988 Phase 2
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Enrollment
110 pts
Location
United States, Austr...
Sponsor
AbbVie
View Trial →